Novo Nordisk A/S (NVO)
63.45
+0.71 +1.13%
NYSE
Feb 14, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 18.29B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.457 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 5.844B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 83.24% |
| Profit Margin (Quarterly) | 26.89% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 1.94% |
| Price and Valuation | |
| Market Cap | 149.09B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.250 |
| PE Ratio | 25.82 |
| Price to Book Value | 17.27 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.0114 |
| Free Cash Flow (Quarterly) | 361.95M |
| Return on Equity | Upgrade |
View All NVO News
News
-
WireHeadlineTime (ET)
-
Yahoo02/13 11:40
-
Yahoo02/12 10:29
-
Yahoo02/09 02:21
-
Yahoo02/09 01:24
-
MT Newswires02/07 10:53
-
Yahoo02/07 10:24
-
Yahoo02/06 12:29
-
Yahoo02/05 16:11
-
Yahoo02/05 11:11
-
MT Newswires02/05 10:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 10/30/2020 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results for 2020 |
| 08/06/2020 | Earnings | Novo Nordisk A/S Second Quarter Earnings Results for 2020 |
| 05/06/2020 | Earnings | Novo Nordisk A/S First Quarter Earnings Results for 2020 |
| 03/27/2020 | Dividends | Amount: 0.7874, Declared Date: Feb 06 2020, Pay Date: Apr 07 2020 |
| 03/26/2020 | Misc | Novo Nordisk A/S Annual General Meeting for 2019 |
| 02/05/2020 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results for 2019 |
| 02/05/2020 | Misc | Novo Nordisk A/S Annual Report for 2019 |
| 11/01/2019 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results in 2019 |
| 08/16/2019 | Dividends | Amount: 0.4452, Declared Date: Aug 05 2019, Pay Date: Aug 27 2019 |
| 08/09/2019 | Earnings | Novo Nordisk A/S Second Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.novonordisk.com
- Investor Relations URL: http://www.novonordisk.com/investors.html
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Growth
- Next Earnings Release: May. 06, 2020
- Last Earnings Release: Feb. 05, 2020
- Next Ex-Dividend Date: Mar. 27, 2020
- Last Ex-Dividend Date: Aug. 16, 2019
- Description: With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 63.45 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| PPH | VanEck Vectors Pharmaceutical ETF | 5.30% |
| LIFE.B.TO | Evolve Global Healthcare Enh YldETFUnHdg | 5.16% |
| HIG.TO | Brompton Global Healthcare Inc & Gr ETF | 4.04% |
| EDGF.TO | Brompton European Dividend Growth ETF | 3.25% |
| LGRCX | Loomis Sayles Growth C | 2.81% |
| AMIGX | Amana Growth Institutional | 2.77% |
| FVUSA000PM | AST Loomis Sayles Large Cap Growth Port | 2.75% |
| PHLBX | PGIM Jennison Health Sciences B | 2.62% |
| AADR | AdvisorShares Dorsey Wright ADR ETF | 2.42% |
| LGGBX | ClearBridge International Growth A2 | 1.97% |
| MBCNX | MassMutual Select Blue Chip Growth R3 | 1.26% |
| PTIN | Pacer Trendpilot International ETF | 0.73% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVO Tweets Stocktwits
Advertisement
